![IJMS | Free Full-Text | Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression IJMS | Free Full-Text | Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression](https://www.mdpi.com/ijms/ijms-25-04061/article_deploy/html/images/ijms-25-04061-g001.png)
IJMS | Free Full-Text | Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression
![Estimate of survival of 867 patients with essential thrombocythemia, by... | Download Scientific Diagram Estimate of survival of 867 patients with essential thrombocythemia, by... | Download Scientific Diagram](https://www.researchgate.net/publication/228082552/figure/fig1/AS:294727196524544@1447279847330/Estimate-of-survival-of-867-patients-with-essential-thrombocythemia-by-IPSET-score.png)
Estimate of survival of 867 patients with essential thrombocythemia, by... | Download Scientific Diagram
![Figure 1 from Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. | Semantic Scholar Figure 1 from Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/43e3ea163dcf2dfab5aa1838c7e8f1a4c3a6a02e/3-Figure1-1.png)
Figure 1 from Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. | Semantic Scholar
![The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis. | Semantic Scholar The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7b835793aa26764bb98a0170cfa34996c49b5a68/2-Table1-1.png)
The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis. | Semantic Scholar
![Austrian recommendations for the management of essential thrombocythemia | Wiener klinische Wochenschrift Austrian recommendations for the management of essential thrombocythemia | Wiener klinische Wochenschrift](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00508-020-01761-3/MediaObjects/508_2020_1761_Fig2_HTML.png)
Austrian recommendations for the management of essential thrombocythemia | Wiener klinische Wochenschrift
![Estimated probability of progression to myelodysplastic syndrome/acute... | Download Scientific Diagram Estimated probability of progression to myelodysplastic syndrome/acute... | Download Scientific Diagram](https://www.researchgate.net/publication/339434624/figure/fig3/AS:960056996671488@1605906833024/Estimated-probability-of-progression-to-myelodysplastic-syndrome-acute-myeloid-leukemia.png)
Estimated probability of progression to myelodysplastic syndrome/acute... | Download Scientific Diagram
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients | Haematologica
![One thousand patients with essential thrombocythemia: the Mayo Clinic experience | Blood Cancer Journal One thousand patients with essential thrombocythemia: the Mayo Clinic experience | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-023-00972-x/MediaObjects/41408_2023_972_Fig1_HTML.png)
One thousand patients with essential thrombocythemia: the Mayo Clinic experience | Blood Cancer Journal
![Frontiers | Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study Frontiers | Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study](https://www.frontiersin.org/files/Articles/637116/fonc-11-637116-HTML/image_m/fonc-11-637116-g001.jpg)
Frontiers | Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
![Cells | Free Full-Text | MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment Cells | Free Full-Text | MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment](https://pub.mdpi-res.com/cells/cells-09-01901/article_deploy/html/images/cells-09-01901-g003.png?1597404913)
Cells | Free Full-Text | MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
![Anand Patel on X: "Below is a chart summarizing the various features of polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). https://t.co/3sQSR55xy2" / X Anand Patel on X: "Below is a chart summarizing the various features of polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). https://t.co/3sQSR55xy2" / X](https://pbs.twimg.com/media/D92TSfLWwAA0Ueh.jpg)
Anand Patel on X: "Below is a chart summarizing the various features of polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). https://t.co/3sQSR55xy2" / X
![Personalized management of essential thrombocythemia—application of recent evidence to clinical practice | Leukemia Personalized management of essential thrombocythemia—application of recent evidence to clinical practice | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2013.99/MediaObjects/41375_2013_Article_BFleu201399_Fig1_HTML.jpg)